Neuroscience

Neurophet-AriBio to develop ‘Next-Gen Platform for Alzheimer’s diagnosis’Neurophet-AriBio to develop ‘Next-Gen Platform for Alzheimer’s diagnosis’

Neurophet-AriBio to develop ‘Next-Gen Platform for Alzheimer’s diagnosis’

- Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease…

8 months ago
Perceiv AI Welcomes Simona Skerjanec to Board of DirectorsPerceiv AI Welcomes Simona Skerjanec to Board of Directors

Perceiv AI Welcomes Simona Skerjanec to Board of Directors

Thought Leader in Brain Health Joins Richard Stark and Company Co-Founders to Accelerate Innovation in Precision MedicineMONTREAL, QC / ACCESSWIRE…

8 months ago
Awakn Partners with the University of Nottingham for in Vivo Testing of Aminoindane New Chemical Entity (NCE) Pre-Clinical ProgramAwakn Partners with the University of Nottingham for in Vivo Testing of Aminoindane New Chemical Entity (NCE) Pre-Clinical Program

Awakn Partners with the University of Nottingham for in Vivo Testing of Aminoindane New Chemical Entity (NCE) Pre-Clinical Program

Toronto, Ontario--(Newsfile Corp. - October 15, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

8 months ago
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with DepressionNeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

Data selected for oral presentation reinforce previous findings on safety and efficacyMALVERN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Neuronetics,…

8 months ago
Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience MeetingAlterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting

Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting

MELBOURNE, Australia and SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the…

8 months ago
Five to Flow® Unveils Next-Generation Wellness Wave® Diagnostic for Improved Workplace Wellness and Productivity, Supporting World Mental Health Day’s Workplace Well-Being FocusFive to Flow® Unveils Next-Generation Wellness Wave® Diagnostic for Improved Workplace Wellness and Productivity, Supporting World Mental Health Day’s Workplace Well-Being Focus

Five to Flow® Unveils Next-Generation Wellness Wave® Diagnostic for Improved Workplace Wellness and Productivity, Supporting World Mental Health Day’s Workplace Well-Being Focus

The enhanced employee sentiment tool equips employees and leaders to address stress, burnout, disengagement, and turnover for lasting growth and…

8 months ago
Healthy Minds Innovations Unveils Breakthrough Wellbeing Index for Teens and Adults, and the “Our World of Emotions” CampaignHealthy Minds Innovations Unveils Breakthrough Wellbeing Index for Teens and Adults, and the “Our World of Emotions” Campaign

Healthy Minds Innovations Unveils Breakthrough Wellbeing Index for Teens and Adults, and the “Our World of Emotions” Campaign

MADISON, Wis., Oct. 10, 2024 /PRNewswire/ -- In recognition of World Mental Health Day, Healthy Minds Innovations (HMI) proudly announces…

8 months ago
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor ForumMagdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor Forum

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor Forum

Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription…

8 months ago
BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South KoreaBrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea

BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea

BURLINGTON, Mass. and JERUSALEM, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the…

8 months ago